DE60042153D1 - Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen - Google Patents

Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen

Info

Publication number
DE60042153D1
DE60042153D1 DE60042153T DE60042153T DE60042153D1 DE 60042153 D1 DE60042153 D1 DE 60042153D1 DE 60042153 T DE60042153 T DE 60042153T DE 60042153 T DE60042153 T DE 60042153T DE 60042153 D1 DE60042153 D1 DE 60042153D1
Authority
DE
Germany
Prior art keywords
treatment
nitrate
pharmacetic
anhibitors
burns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60042153T
Other languages
English (en)
Inventor
Arthur Tudor Tucker
Nigel Benjamin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queen Mary University of London
Original Assignee
Queen Mary and Westfiled College University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary and Westfiled College University of London filed Critical Queen Mary and Westfiled College University of London
Application granted granted Critical
Publication of DE60042153D1 publication Critical patent/DE60042153D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DE60042153T 1999-03-09 2000-03-09 Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen Expired - Lifetime DE60042153D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9905425.6A GB9905425D0 (en) 1999-03-09 1999-03-09 Pharmaceutical composition
PCT/GB2000/000853 WO2000053193A1 (en) 1999-03-09 2000-03-09 Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia

Publications (1)

Publication Number Publication Date
DE60042153D1 true DE60042153D1 (de) 2009-06-18

Family

ID=10849290

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60042153T Expired - Lifetime DE60042153D1 (de) 1999-03-09 2000-03-09 Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen

Country Status (11)

Country Link
US (3) US20020090401A1 (de)
EP (1) EP1161248B1 (de)
JP (1) JP5084985B2 (de)
AT (1) ATE430573T1 (de)
AU (1) AU2931500A (de)
DE (1) DE60042153D1 (de)
DK (1) DK1161248T3 (de)
ES (1) ES2326729T3 (de)
GB (1) GB9905425D0 (de)
PT (1) PT1161248E (de)
WO (1) WO2000053193A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780849B2 (en) 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
WO2003020211A2 (en) * 2001-09-05 2003-03-13 Cyterra Corporation Nitric oxide generation
US9675637B2 (en) 2003-07-09 2017-06-13 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US7618594B2 (en) 2004-08-18 2009-11-17 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
CA2576957C (en) 2004-08-18 2013-04-02 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
EP1871433B1 (de) * 2005-03-24 2009-04-22 NOLabs AB Kosmetische behandlung mit stickoxid, vorrichtung zur durchführung dieser behandlung und herstellungsverfahren dafür
EP2669269B1 (de) 2005-05-27 2019-05-22 The University of North Carolina At Chapel Hill Stickoxidfreisetzende partikel für stickoxidtherapeutika und biomedizinische anwendungen
GB0607402D0 (en) 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
CA2730009C (en) * 2007-07-12 2017-08-15 Whipbird Pain Relief Pty Ltd. Topical medicament
US9278157B2 (en) 2007-08-09 2016-03-08 Insense Limited Nitric oxide-generating skin dressings
GB0715556D0 (en) * 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
WO2009055008A1 (en) * 2007-10-24 2009-04-30 Wharton Innovative Products, Llc Two part lotion for the delivery of nitrite ions to the skin
US8980332B2 (en) 2007-10-30 2015-03-17 The Invention Science Fund I, Llc Methods and systems for use of photolyzable nitric oxide donors
US10080823B2 (en) 2007-10-30 2018-09-25 Gearbox Llc Substrates for nitric oxide releasing devices
US8877508B2 (en) 2007-10-30 2014-11-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
US9649334B2 (en) 2007-11-15 2017-05-16 The Uab Research Foundation Use of nitrite salts in chronic ischemia
US20090196930A1 (en) * 2007-12-27 2009-08-06 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
WO2009097343A1 (en) 2008-01-28 2009-08-06 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
US20110106000A1 (en) * 2008-06-24 2011-05-05 Micropharma Limited Nitric Oxide Compositions and Devices and Methods for Cosmesis
US8607785B2 (en) 2008-08-21 2013-12-17 Geno Llc Systems and devices for generating nitric oxide
WO2010147742A2 (en) 2009-06-18 2010-12-23 Theravasc Inc. Use of nitrite salts in treating tissue damage
EP2445508B1 (de) 2009-06-22 2018-11-14 VERO Biotech LLC Stickoxidtherapien
DK2467173T3 (da) 2009-08-21 2019-07-29 Novan Inc Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf
BR112012003792B1 (pt) 2009-08-21 2020-05-19 Novan Inc composição tópica, e, uso da composição tópica
AU2010306755B2 (en) 2009-10-14 2015-12-24 Theravasc Inc. Pharmaceutical formulations of nitrite and uses thereof
EP2501427B1 (de) * 2009-11-20 2018-03-21 Geno LLC Stickoxidausgabesystem
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
KR20160120785A (ko) 2011-08-17 2016-10-18 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 경구 전달 시스템을 통해 생리학적 및 치료학적 수준의 일산화질소를 생산하는 방법
CA2899602C (en) 2013-02-20 2024-01-30 Theravasc Inc. Pharmaceutical uses of inorganic nitrites
GB201309091D0 (en) * 2013-05-20 2013-07-03 Edixomed Ltd Dressing system
GB201309092D0 (en) 2013-05-20 2013-07-03 Edixomed Ltd Transdermal delivery system
GB201420761D0 (en) 2014-11-21 2015-01-07 Edixomed Ltd And First Water Ltd Dressing system
TWI562038B (en) * 2015-07-08 2016-12-11 Wistron Corp Method of detecting touch position and touch apparatus thereof
GB201520990D0 (en) 2015-11-27 2016-01-13 Edixomed Ltd Dressing system
WO2020227367A1 (en) * 2019-05-06 2020-11-12 Pneuma Nitric Oxide, Llc Nitric oxide compositions and topical uses thereof
BR112021023632A2 (pt) 2019-06-04 2022-04-19 Thirty Respiratory Ltd Métodos e composições para gerar óxido nítrico e usos do mesmo para entregar óxido nítrico através do trato respiratório
AU2020286677A1 (en) 2019-06-04 2021-12-09 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
CN115884758A (zh) 2020-04-23 2023-03-31 三十呼吸有限公司 用于治疗SARS-CoV和SARS-CoV-2的一氧化氮或释放一氧化氮的组合物
US20230172973A1 (en) 2020-04-23 2023-06-08 Thirty Respiratory Limited Methods and compositions for treating and combatting tuberculosis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH629100A5 (de) * 1979-09-27 1982-04-15 Solco Basel Ag Hautpraeparat.
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
ZA933895B (en) * 1992-06-08 1993-12-27 Pitmy Int Nv Dermatological composition
EP0746327B1 (de) * 1994-02-21 2004-04-21 Aberdeen University Angesäuertes nitrit zur verwendung als antimikrobielles mittel
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
JP3002772B2 (ja) * 1996-05-15 2000-01-24 マルホ株式会社 貼付剤及びその製造法
US6207713B1 (en) * 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
US7404990B2 (en) * 2002-11-14 2008-07-29 Air Products And Chemicals, Inc. Non-thermal process for forming porous low dielectric constant films
US7056840B2 (en) * 2003-09-30 2006-06-06 International Business Machines Corp. Direct photo-patterning of nanoporous organosilicates, and method of use

Also Published As

Publication number Publication date
US20020090401A1 (en) 2002-07-11
ES2326729T3 (es) 2009-10-19
EP1161248A1 (de) 2001-12-12
JP5084985B2 (ja) 2012-11-28
PT1161248E (pt) 2009-08-05
US20150004258A1 (en) 2015-01-01
EP1161248B1 (de) 2009-05-06
JP2002538210A (ja) 2002-11-12
DK1161248T3 (da) 2009-08-31
WO2000053193A1 (en) 2000-09-14
ATE430573T1 (de) 2009-05-15
AU2931500A (en) 2000-09-28
GB9905425D0 (en) 1999-05-05
US20080226751A1 (en) 2008-09-18

Similar Documents

Publication Publication Date Title
DE60042153D1 (de) Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen
ES2275716T3 (es) Composicion farmaceutica de liberacion transdermica.
MXPA02002895A (es) Tratamiento topico de infecciones por estreptococcus.
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
SE9701162D0 (sv) New use II
EA200101166A1 (ru) Ингибиторы металлопротеаз
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
DE69532921D1 (de) Angesäuertes nitrit zur verwendung als antimikrobielles mittel
NZ513096A (en) Compositions for treating inflammatory response
ES2194003T3 (es) Huperzina a racemica.
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
ATE541565T1 (de) Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
ATE232390T1 (de) Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs
ATE390124T1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
SE0004101D0 (sv) New use
ATE310539T1 (de) Artikel zur wundbehandlung
DE60239670D1 (de) Verwendung von oxytocin zur herstellung einer pharmazeutischen zusammensetzung gegen karzinom in situ und zervizitis
RU95113437A (ru) (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью
SE0000303D0 (sv) Novel compounds
ATE286890T1 (de) Biologisch wirksame, analoge verbindungen von discodermoliden
DE69814691T2 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DK227090D0 (da) Organisk guldkompleks til topisk anvendelse

Legal Events

Date Code Title Description
8364 No opposition during term of opposition